2 reports

  • Infant Bacterial Therapeutics AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • BIOGAIA TO INVEST USD4.1 MILLION IN INFANT BACTERIAL THERAPEUTICS

Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants.Its pipeline product candidates include IBP-9414, containing the active substance Lactobacillus reuteri, co-evolved...

  • Pharmaceutical
  • Sweden
  • United States
  • Company
  • BioGaia Group

Pharmaceuticals and Healthcare--> Pharmaceuticals-- > Manufacturing Services and Outsourcing--> Packaging ##, Bd Eiffel, ZI Dijon Longvic Longvic Cedex PARTNER ##: BERICAP S. A. R. L.

  • Healthcare
  • Pharmaceutical
  • Company
  • BioGaia Group